MolNFT v1 · #100832 · protein
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (nampt)
4N9D: “Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide…”. X-ray diffraction. MolNFT v1 #100832 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4N9D
- Type
- protein
- Length
- 939 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P43490
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 469 | — | P43490 |
| B | — | protein | 470 | — | P43490 |
Compared structures
- 4N9D · Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human… · the same entry in another collection · chain B against B, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P43490
- Elsewhere: RCSB PDB 4N9D · PDBe 4N9D · UniProt P43490
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.